Biogen Pharmachem [BIOGEN] vs Monarch Networth [MONARCH] Detailed Stock Comparison

Biogen Pharmachem

BSE

Monarch Networth

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Biogen Pharmachem wins in 7 metrics, Monarch Networth wins in 11 metrics, with 0 ties. Monarch Networth appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Biogen Pharmachem	Monarch Networth	Better
P/E Ratio (TTM)	92.00	16.99	Monarch Networth
Price-to-Book Ratio	0.59	3.29	Biogen Pharmachem
Debt-to-Equity Ratio	0.00	1.16	Biogen Pharmachem
PEG Ratio	-0.18	-6.48	Monarch Networth
EV/EBITDA	-406.61	10.29	Biogen Pharmachem
Profit Margin (TTM)	74.09%	47.16%	Biogen Pharmachem
Operating Margin (TTM)	87.17%	61.51%	Biogen Pharmachem
EBITDA Margin (TTM)	87.17%	61.51%	Biogen Pharmachem
Return on Equity	-0.32%	18.73%	Monarch Networth
Return on Assets (TTM)	-0.32%	12.08%	Monarch Networth
Free Cash Flow (TTM)	$-10.91M	$135.20M	Monarch Networth
Dividend Yield	N/A	0.08%	N/A
1-Year Return	-31.06%	-19.29%	Monarch Networth
Price-to-Sales Ratio (TTM)	50.83	8.01	Monarch Networth
Enterprise Value	$1.19B	$20.24B	Monarch Networth
EV/Revenue Ratio	72.85	6.18	Monarch Networth
Gross Profit Margin (TTM)	N/A	50.44%	N/A
Revenue per Share (TTM)	$0	$43	Monarch Networth
Earnings per Share (Diluted)	$0.01	$19.68	Monarch Networth
Beta (Stock Volatility)	-0.74	0.30	Biogen Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Biogen Pharmachem vs Monarch Networth Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Biogen Pharmachem	-1.09%	3.41%	-2.15%	-10.78%	-11.65%	-22.88%
Monarch Networth	-0.76%	1.20%	-13.00%	6.23%	-4.58%	-23.81%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Biogen Pharmachem	-31.06%	-3.19%	127.50%	127.50%	127.50%	127.50%
Monarch Networth	-19.29%	87.18%	286.90%	286.90%	286.90%	286.90%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Biogen Pharmachem (BIOGEN): View Full Stock Overview

Monarch Networth (MONARCH): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Biogen Pharmachem vs Monarch Networth

Metric	BIOGEN	MONARCH
Market Information
Market Cap i	₹830.39M	₹26.25B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	653,936	342,355
90 Day Avg. Volume i	1,012,415	350,861
Last Close	₹0.91	₹334.40
52 Week Range	₹0.75 - ₹1.45	₹294.50 - ₹499.00
% from 52W High	-37.24%	-32.99%
All-Time High	₹1.85 (Mar 14, 2022)	₹499.00 (Sep 09, 2024)
% from All-Time High	-50.81%	-32.99%
Growth Metrics
Quarterly Revenue Growth	N/A	0.22%
Quarterly Earnings Growth	-1.00%	0.13%
Financial Health
Profit Margin (TTM) i	0.74%	0.47%
Operating Margin (TTM) i	0.87%	0.62%
Return on Equity (TTM) i	0.00%	0.19%
Debt to Equity (MRQ) i	0.00	1.16
Cash & Liquidity
Book Value per Share (MRQ)	₹1.56	₹101.55
Cash per Share (MRQ)	₹0.02	₹80.47
Operating Cash Flow (TTM) i	₹-10,911,000	₹359.79M
Levered Free Cash Flow (TTM) i	₹-2,927,000	₹1.49B
Dividends
Last 12-Month Dividend Yield i	N/A	0.08%
Last 12-Month Dividend i	N/A	₹0.25

Valuation & Enterprise Metrics Analysis: Biogen Pharmachem vs Monarch Networth

Metric	BIOGEN	MONARCH
Price Ratios
P/E Ratio (TTM) i	92.00	16.99
Forward P/E i	N/A	N/A
PEG Ratio i	-0.18	-6.48
Price to Sales (TTM) i	50.83	8.01
Price to Book (MRQ) i	0.59	3.29
Market Capitalization
Market Capitalization i	₹830.39M	₹26.25B
Enterprise Value i	₹1.19B	₹20.24B
Enterprise Value Metrics
Enterprise to Revenue i	72.85	6.18
Enterprise to EBITDA i	-406.61	10.29
Risk & Other Metrics
Beta i	-0.74	0.30
Book Value per Share (MRQ) i	₹1.56	₹101.55

Financial Statements Comparison: Biogen Pharmachem vs Monarch Networth

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BIOGEN	MONARCH
Revenue/Sales i	₹0	₹348.65M
Cost of Goods Sold i	₹633,000	₹172.79M
Gross Profit i	₹-633,000	₹175.86M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹13.45M	₹-23.15M
EBITDA i	₹13.45M	₹240.25M
Pre-Tax Income i	₹13.45M	₹595.11M
Income Tax i	₹0	₹142.61M
Net Income (Profit) i	₹13.45M	₹452.51M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BIOGEN	MONARCH
Cash & Equivalents i	₹548,000	₹1.63B
Total Current Assets i	₹26.56M	₹10.72B
Total Current Liabilities i	₹900,000	₹3.41B
Long-Term Debt i	₹0	₹91.99M
Total Shareholders Equity i	₹919.28M	₹7.97B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BIOGEN	MONARCH
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	BIOGEN	MONARCH
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	653,936	342,355
Average Daily Volume (90 Day) i	1,012,415	350,861
Shares Outstanding i	652.60M	78.46M
Float Shares i	1.10B	22.46M
% Held by Insiders i	0.41%	0.72%
% Held by Institutions i	0.00%	0.01%

Dividend Analysis & Yield Comparison: Biogen Pharmachem vs Monarch Networth

Metric	BIOGEN	MONARCH
Last 12-Month Dividend i	N/A	₹0.25
Last 12-Month Dividend Yield i	N/A	0.08%
3-Year Avg Annual Dividend i	N/A	₹0.25
3-Year Avg Dividend Yield i	N/A	0.12%
3-Year Total Dividends i	N/A	₹0.75
Ex-Dividend Date	N/A	Aug 02, 2024

Biogen Pharmachem [BIOGEN] vs Monarch Networth [MONARCH] Detailed Stock Comparison